How do I set a price alert for RGT.AX?

To set a RGT.AX price alert on Stock Alarm Pro, navigate to the RGT.AX quote page, select "Set Alert," choose your trigger type (price target, % move, RSI level, MACD, or volume breakout), and set your delivery channel. Stock Alarm Pro supports instant push notifications, SMS, and automated phone call alerts.

Can I get phone call alerts for RGT.AX?

Yes. Stock Alarm Pro provides real-time automated phone call alerts for RGT.AX. Phone call alerts ensure you are immediately awakened or interrupted during critical volatility events, overnight earnings moves, or strict stop-loss levels when silent push notifications might be overlooked.

What types of alerts can I set for RGT.AX?

Stock Alarm Pro supports over 125 trigger types for RGT.AX: price target alerts (above/below target), intraday percentage moves, RSI overbought/oversold levels, 50-day and 200-day moving average crossovers (golden cross / death cross), relative volume (RVOL) spikes, confirmed earnings date releases, and SEC Form-4 insider transaction filings.

How quickly will I be notified about RGT.AX price changes?

RGT.AX alerts are evaluated continuously in real-time against live market telemetry. Notifications are dispatched within sub-second latency via push notifications, SMS, or phone calls as soon as your trigger condition is met across regular, pre-market, and after-hours trading sessions.

Is Stock Alarm Pro free to use for RGT.AX alerts?

Yes, Stock Alarm Pro offers a free tier that includes 3 active price alerts for RGT.AX and other stocks. Full Pro membership is $20/month or $168/year with a 7-day free trial, unlocking unlimited alerts, phone call delivery, SMS, all 125+ technical indicators, institutional screeners, and real-time market telemetry across web, iOS, and Android.

RGT.AX Company Intelligence - Business Model, Drivers & Risks

RGT.AX(RGT.AX)

ASXLast print unknown agoAbout this dataData status

$0.02▲0.00 (0.00%)Stale · unknown old

WatchlistChart Studio

RGT.AX(RGT.AX)

RGT.AX

Argent BioPharma Limited focuses on developing specialty pharmaceuticals, primarily targeting rare diseases and niche therapeutic areas. Its competitive position is bolstered by a proprietary drug delivery platform that enhances the efficacy of existing treatments, particularly in oncology and autoimmune disorders.

HealthcareDrug Manufacturers - Specialty & Genericlow - The company has high fixed costs associated with R&D and regulatory compliance, which limits its ability to scale efficiently.

Business Overview

01Sales of proprietary drug formulations - 70%

02Partnership revenues from licensing agreements - 20%

03Research and development services - 10%

Argent generates revenue through the sale of its proprietary drug formulations, which leverage a unique delivery mechanism that improves patient outcomes. The company also engages in licensing agreements with larger pharmaceutical firms, providing a steady stream of partnership revenues. Their focus on rare diseases allows for higher pricing power due to limited competition.

What Moves the Stock

FDA approval of new drug candidates, particularly in oncology

Partnership announcements with larger pharmaceutical companies

Clinical trial results that exceed market expectations

Changes in regulatory policies affecting drug pricing

Watch on Earnings

Revenue from new drug launchesPartnership revenue growthClinical trial success rates

Risk Factors

Regulatory changes that could impact drug approval timelines

Technological advancements by competitors that could render Argent's products less effective

Emergence of generic alternatives for existing therapies

Increased competition from larger pharmaceutical companies entering niche markets

High cash burn rate due to ongoing R&D expenditures

Limited liquidity given the current negative cash flow

StructuralCompetitiveBalance Sheet

Macro Sensitivity

Economic Cycle

moderate - The demand for specialty pharmaceuticals can be somewhat insulated from economic cycles, but overall healthcare spending is influenced by GDP growth.

Interest Rates

Interest rates affect Argent's financing costs for R&D projects, as higher rates could increase borrowing costs, impacting cash flow and investment in new drug development.

Credit

minimal - The company operates with a low debt profile, reducing sensitivity to credit market fluctuations.

Live Conditions

Dow Jones FuturesS&P 500 FuturesRussell 2000 Futures